Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

106
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
106
Birth Control Methods01:22

Birth Control Methods

7.2K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
7.2K
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

165
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
165
Modified-Release Drug Delivery Systems: Drug Release Characteristics01:22

Modified-Release Drug Delivery Systems: Drug Release Characteristics

138
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
138
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

83
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
83
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

388
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
388

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brunner's gland hamartoma masquerading as duodenal stricture: a case report.

Annals of medicine and surgery (2012)·2025
Same author

Takayasu's arteritis in pregnancy: A case report and literature review.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2024
Same author

First Trimester Abortion and Psychiatric Morbidity.

Journal of Nepal Health Research Council·2024
Same author

Intrauterine pregnancy with copper intrauterine contraceptive device in situ: A case report from Nepal.

Annals of medicine and surgery (2012)·2022
Same author

An insight into two decades of Skilled Birth Attendants in Nepal.

Frontiers in global women's health·2022
Same author

Abnormal Uterine Bleeding among Women Visiting Gynecology Out- patient Department of a Tertiary Care Hospital: A Descriptive Cross- sectional Study.

JNMA; journal of the Nepal Medical Association·2022

Related Experiment Video

Updated: Mar 20, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.5K

Profile of Long Acting Reversible Contraceptive Users.

Shreyashi Aryal1, Kristina Shakya1, Prabesh Adhikari2

  • 1Department of Obstetrics and Gynecology, Kathmandu Medical College and Teaching Hospital , Sinamangal, Kathmandu, Nepal.

Journal of Nepal Health Research Council
|March 19, 2026
PubMed
Summary

The subdermal implant is the most chosen long-acting reversible contraceptive (LARC). Socio-demographic factors like caste and education significantly influence women's LARC choices.

Keywords:
Contraception; drug implant; intrauterine device; LARC.

More Related Videos

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

3.2K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.1K

Related Experiment Videos

Last Updated: Mar 20, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.5K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

3.2K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.1K

Area of Science:

  • Reproductive Health
  • Contraception
  • Sociology

Background:

  • Long-acting reversible contraceptives (LARCs) are safe and effective, crucial for increasing modern contraceptive use.
  • Women's reproductive health conditions and socio-economic background influence LARC utilization.
  • Understanding characteristics of women choosing LARCs is vital for reproductive health strategies.

Purpose of the Study:

  • To explore the characteristics of women of reproductive age who selected long-acting reversible contraceptive methods.
  • To identify factors influencing the choice of specific LARC methods.

Main Methods:

  • A cross-sectional study involving 74 women (15-49 years) at Kathmandu Medical College.
  • Convenience sampling and ethical approval were obtained.
  • Demographic and obstetric data were collected and analyzed using SPSS version 21 with descriptive statistics.

Main Results:

  • 37.33% of women seeking contraception chose LARCs.
  • The subdermal implant was the most preferred LARC method.
  • Levonorgestrel intrauterine devices were preferred by older women (mean age 38) compared to copper IUDs (33.67) and subdermal implants (32.49).
  • The majority of users (66.21%) belonged to the Brahmin/Chhetri caste.

Conclusions:

  • The subdermal implant is the most favored Long Acting Reversible Contraceptive method.
  • Caste and education levels significantly impact contraceptive choices.
  • Socio-demographic and reproductive health factors play a crucial role in selecting long-term birth control methods.